Hydroxychloroquine Sulfate HCQS Market Analysis 2026

Global Hydroxychloroquine Sulfate HCQS Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Hydroxychloroquine Sulfate HCQS Market Report Description

We have various report editions of Hydroxychloroquine Sulfate HCQS Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Competitive Landscape of the Hydroxychloroquine Sulfate HCQS Market

The competitive landscape of the hydroxychloroquine sulfate (HCQS) market is characterized by several pharmaceutical companies involved in the manufacturing and distribution of generic and branded versions. Companies focus on expanding production capacity, improving drug formulations, and increasing market access, particularly in emerging regions. Intense price competition in the generic segment drives cost reductions, while regulatory and safety concerns shape market dynamics and product offerings.

In March 2020, Sun Pharmaceutical Industries, Inc. (SPII) announced the donation of 2.5 million hydroxychloroquine sulfate tablets in the United States. The donation aimed to support healthcare professionals in meeting rising patient demand while clinical trials assessed its potential for treating COVID-19. Sun Pharma's hydroxychloroquine tablets were FDA-approved for conditions like malaria, lupus, and rheumatoid arthritis. (Source: https://www.businesswire.com/news/home/20200327005470/en/Sun-Pharmaceutical-Industries-Inc.-Donates-2.5-Million-Hydroxychloroquine-Sulfate-Tablets-in-the-U.S.-For-Potential-COVID-19-Treatment) In November 2020, Jubilant Pharma Ltd. and Aavis Pharmaceuticals Inc. announced the launch of Hydroxychloroquine Sulfate tablets, 200 mg, a therapeutic equivalent of Plaquenil (hydroxychloroquine sulfate) 200 mg in the U.S. market. The product was distributed by Jubilant Cadista, a subsidiary of Jubilant Pharma Ltd. Hydroxychloroquine Sulfate Tablets were indicated for the treatment of malaria, lupus erythematosus, and rheumatoid arthritis. (Source: https://www.prnewswire.com/in/news-releases/jubilant-pharma-ltd-and-aavis-pharmaceuticals-launch-hydroxychloroquine-sulfate-tablets-in-the-u-s-market-843480045.html)

Top Companies Market Share in Hydroxychloroquine Sulfate HCQS Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Hydroxychloroquine Sulfate HCQS Market

Which Region Dominates the Hydroxychloroquine Sulfate HCQS Market in 2024?

According to Cognitive Market Research, North America currently dominates the Hydroxychloroquine Sulfate HCQS market, and the region is expected to have significant growth during the projected period. The region’s strong pharmaceutical research capabilities, along with increasing awareness of autoimmune diseases, contribute to its leading market position and sustained growth in demand for HCQS across therapeutic and off-label uses.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Increased healthcare access, expanding pharmaceutical infrastructure, and growing awareness contribute to the rapid market growth, positioning the region as a key player in global HCQS demand and distribution.

The current report Scope analyzes Hydroxychloroquine Sulfate HCQS Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Hydroxychloroquine Sulfate HCQS Market Analysis

According to Cognitive Market Research, the global Hydroxychloroquine Sulfate HCQS market size was estimated at USD 1362.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 545.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Hydroxychloroquine Sulfate HCQS market with a market size of USD 430.04 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. The US holds a major share in the hydroxychloroquine sulfate market due to high autoimmune disease cases.
• The Canada Hydroxychloroquine Sulfate HCQS market had a market share of USD 65.40 million in 2024 and is projected to grow at a CAGR of 12.2% during the forecast period. Canada's hydroxychloroquine sulfate market is growing rapidly due to increasing autoimmune disease cases and expanding medical applications.
• The Mexico Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 49.60 million in 2024.

Europe Hydroxychloroquine Sulfate HCQS Market Analysis

According to Cognitive Market Research, the global Hydroxychloroquine Sulfate HCQS market size was estimated at USD 1362.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 408.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.7% from 2024 to 2031.

• The United Kingdom Hydroxychloroquine Sulfate HCQS market had a market share of USD 68.68 million in 2024 and is projected to grow at a CAGR of 12.5% during the forecast period. The UK leads the hydroxychloroquine sulfate market with advanced healthcare facilities and strong pharmaceutical innovation capabilities.
• The France Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 10.9% during the forecast period, with a market size of USD 37.61 million in 2024.
• According to Cognitive Market Research, the German Hydroxychloroquine Sulfate HCQS market size was valued at USD 80.94 million in 2024 and is projected to grow at a CAGR of 11.9% during the forecast period. Germany's hydroxychloroquine sulfate market grows steadily due to advanced healthcare infrastructure and increasing pharmaceutical innovations.
• The Italy Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 35.16 million in 2024.
• The Russia Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 63.36 million in 2024.
• The Spain Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 10.8% during the forecast period with a market size of USD 33.52 million in 2024
• The Luxembourg Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.8% during the forecast period, with a market size of USD 12.67 million in 2024.
• The Portugal Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 8.58 million in 2024.
• The Greece Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 4.91 million in 2024.
• The Rest of Europe's Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 63.36 million in 2024.

Asia Pacific Hydroxychloroquine Sulfate HCQS Market Analysis

According to Cognitive Market Research, the global Hydroxychloroquine Sulfate HCQS market size was estimated at USD 1362.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 313.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Hydroxychloroquine Sulfate HCQS market size was valued at USD 141.03 million in 2024 and is projected to grow at a CAGR of 14.7% during the forecast period. China commands the largest share of the hydroxychloroquine sulfate market due to high disease prevalence and extensive healthcare access.
• The Japan Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 43.25 million in 2024.
• The India Hydroxychloroquine Sulfate HCQS market had a market share of USD 37.61 million in 2024 and is projected to grow at a CAGR of 17.0% during the forecast period. India's hydroxychloroquine sulfate market is growing rapidly due to increasing cases of malaria and autoimmune diseases.
• The South Korean Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 31.34 million in 2024.
• The Australian Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 16.30 million in 2024.
• The South East Asia Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 16.2% during the forecast period, with a market size of USD 21.62 million in 2024.
• The Rest of the Asia Pacific Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 15.0% during the forecast period, with a market size of USD 22.25 million in 2024.

South America Hydroxychloroquine Sulfate HCQS Market Analysis

According to Cognitive Market Research, the global Hydroxychloroquine Sulfate HCQS market size was estimated at USD 1362.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 68.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Hydroxychloroquine Sulfate HCQS market size was valued at USD 29.16 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. Brazil dominates the hydroxychloroquine sulfate market due to high malaria incidence and growing healthcare infrastructure.
• Argentina's Hydroxychloroquine Sulfate HCQS market had a market share of USD 11.45 million in 2024 and is projected to grow at a CAGR of 13.5% during the forecast period. Argentina's hydroxychloroquine sulfate market is growing due to increased demand for malaria and autoimmune disease treatments.
• Colombia Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 6.06 million in 2024.
• Peru Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.8% during the forecast period, with a market size of USD 5.59 million in 2024.
• Chile Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 4.91 million in 2024.
• The Rest of Latin America's Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 10.97 million in 2024.

Middle East Hydroxychloroquine Sulfate HCQS Market Analysis

According to Cognitive Market Research, the global Hydroxychloroquine Sulfate HCQS market size was estimated at USD 1362.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 27.25 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.9% from 2024 to 2031..

• The GCC Countries Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 11.66 million in 2024. GCC Countries maintain a prominent share in the hydroxychloroquine sulfate market due to improved healthcare infrastructure and disease management.
• The Egypt Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 2.86 million in 2024.
• The South Africa Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 4.31 million in 2024. South Africa's hydroxychloroquine sulfate market is expanding due to rising cases of malaria and autoimmune diseases.
• The Turkey Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 2.34 million in 2024.
• The Nigeria Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 12.0% during the forecast period, with a market size of USD 2.86 million in 2024.
• The Rest of the MEA Hydroxychloroquine Sulfate HCQS market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 3.22 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.